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F rom　 the　 part　 soluble　 at　pH　 6.4 of　 tryptic　 hydrolyzate　 of　 β-chain　 in
Macaca mulatta monkey hemoglobin, the so-called `soluble tryptic peptides' 
were isolated and purified by column and paper chromatography. Four of
these　 peptides,　 which　 were　 called βT9, βT13, βT14,　 and βT15,　 were　 hyd-
rolyzed with pepsin and isolated by column and paper chromatography. 
Then, amino acid compositions of the four peptides were analyzed and sequ-
ences were determined by the DNP and PTC methods. 
   The results were compared respectively with the amino acid sequences 
of the corresponding peptides in human hemoglobin. Differences between the
two　 hemoglobins　 were　 found　 in βT9　 and βT13,　 namely,　 human　 hemoglobin
has　 alanine　 at　 the　 tenth　 position　 from　 the　 N-terminus　 of βT9,　 whereas
macaca mulatta monkey hemoglobin has asparagine. Similarly, the former
has　 proline　 at　 the　 fifth　 position　 from　 the　 N-terminus　 of　βT13,　 whereas　 the
latter, glutamine. The sequence of the remaining forty amino acid residues 
were all the same with each other.
                  INTRODUCTION 
   It is said that amino acid sequences of proteins which are produced 
in living things are under the control of gene, presumably DNA. 
However, at the present stage that the structure of DNA has not been 
wholly elucidated, investigations on specificities in the primary struct-
ures of proteins will give some valuable information to evolutional 
problems from the viewpoint of molecular level. In this respect, hemo-
globin is one of good materials owing to its wide distribution and com-
paratively easy isolation and purification. 
   The primary structure of human adult hemoglobin has been already
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determined by BRAUNITZER et al.') and KONIGSBERG et al. '1 It seems very 
interesting to inquire into differences in the primary structure between 
human adult and monkey adult hemoglobins from the evolutional point 
of view. 
    It was reported that macaca mulatta monkey hemoglobin closely re-
sembled human hemoglobin immunologically,191 chromatographically, 18) 
elect rophoretically'81 and in alkali-denaturation.3' However, ZUCKERKA-
NDEL et al.25j compared the tryptic peptides of these two hemoglobins 
by the fingerprint method and pointed out the slight differences between 
them. 
   In our laboratory, various kinds of investigations have been carried 
out in order to discover differences in the primary structure between 
human and macca mulatta monkey hemoglobin. 9)14)15)16)20)22) According to 
the results obtained so far, these two adult hemoglobins differ in their 
amino acid compositions by having five differences in the three tryptic 
peptides soluble at pH 6.4 in (/-chain, and six differences in n-chain. 
In order to demonstrate these differences clearer, amino acid sequence 
of each tryptic peptides must be determined. 
   The present paper reports the determination of amino acid sequences 
of 9T9, 9T13, 8T14, and 9T15 among tryptic peptides from 9-chain in 
macaca mulatta monkey hemoglobin. 
              MATERIALS AND METHODS 
   1) Preparation of Tryptic Peptides 
   Isolation and purification of the tryptic peptides from 9-chain in 
macaca mulatta monkey hemoglobin were performed by the methods 
reported previously by TAKEI22) 
   According to DRABKIN' S method, 4) hemoglobin was obtained from 
blood of macaca mulatta monkeys. It was dehemed to obtain globin by 
TEALE' S method. 23) The globin was separated into a- and ,9-chains by 
countercurrent distribution methods" by using a system of sec.-butanol 
containing 0.08% trichloroacetic acid, propionic acid, and water (8.7: 
1.8: 11.0). 9-chain was denatured in 8M urea at 60°C for 45 minutes. 
After it was dialysed against water to remove urea, it was hydrolyzed 
with trypsin at 37°C at pH 8.0 for four hours. This hydrolyzate was 
adjusted to pH 6.4. Consequently, the so-called `core' was precipitated, 
and then removed by centrifugation. From the remaining soluble 
part, the so-called `soluble tryptic peptides' were isolated and purified 
by column and paper chromatography. The column chromatography 
was developed on Dowex 1 x 2 with acetate buffer containing some 
organic bases such as pyridine, collidine, and lutidine. Descending 
paper chromatography was employed with the system of n-butanol, 
acetic acid, and water (4 : 1 : 5). A portion of each tryptic peptide
thus isolated was subjected to amino acid analysis to assess its quantity 
and purity. 
   2) Digestion of the Peptides with Pepsin 
   A sample of each tryptic peptide (15-20 umole) was dissolved in 
15 ml of deionized water and adjusted to pH 2.0 with 1.0 N HC1. To 
this solution was added 4 mg of pepsin ( Thrice- crystallyzed, Sigma) 
which was dissolved in 2 ml of 1/16 N HC1. Digestion was performed 
at 37 °C for the appropriate time and stopped by adding 1.0 N NaOH to 
the reaction mixture which was consequently brought to pH 9.0. 
   3) Resolution of the Peptic Peptides by Column Chromatography
   The resin (Dowex 1 x 2, 200-400 mesh) was washed with 1N NH4OH, 
water, acetic acid, and water. It was suspended with the starting 
buffer, evacuated thoroughly, and filled up in a column (1.0cm x 60cm) . 
The column was fully equilibrated again with the starting buffer. The 
peptic digest of each tryptic peptide was put on the column. The 
acetate buffer containing some organic bases such as pyridine, 
collidine, and picoline was used as the starting buffer of the developer. 
Next, pH gradient was carried out with acetic acid. (see Fig 1, 3, 5) 
The development was performed at 37°C by keeping a flow rate of 
100 ml/h. The effluent was collected into 8 ml fractions by a fraction 
-collector . A portion of each fraction (0.3 ml) was subjected to ninhy-
drin reaction after alkali-hydrolysis, according to YEMM and COCKING'S 
method.24) The fractions positive to this reaction were combined toge-
ther, evaporated to dryness under reduced pressure below 30 C. It was 
dissolved in deionized water. 
   4) Identification and Purification of the Peptides by Paper Chromatography 
   Descending paper chromatography was employed by using Toyo 
filter paper No. 50. The upper phase of the system of n-butanol, acetic 
acid, and water (4: 1 : 5) was used as a developer. For the detection 
of the peptides on the paper chromatogram, 0.2 % ninhydrin-n-butanol 
solution was sprayed on the paper and heated with an iron to color. 
In addition, PAULI's reactionzl) and a-nitrosonaphtol reactions' were 
employed in order to locate the peptides containing histidine and 
tyrosine. In case of purification of the peptides with the above-menti-
oned system, elution of the peptide from the paper was done by using 
5 % acetic acid. 
   5) Paper Electrophoresis of the da(Jppas 
   Electrophoresis was carried out at 2 KV for two hours on an electro-
phoretic apparatus (Ishidai-type) by usiu2 Toyo filter paper No. 51 (10 
cm x 60cm) and pyridine acetate buffer, pH 6.4 (pyridine : acetic acid : 
water= 100: 4 : 900). The peptides were detected by ninhydrin reaction 
as in case of the paper chromatography described previously.
   6) DNP-Method for the N-Terminal Amino Acid Analysis of the Peptides 
   Each peptide (0.2-0.5 pmole) was dissolved in 3 ml of 1 % NaHCO3i 
and to this was added 0.05 ml of dinitrofluorobenzene (DNFB). After 
it was dinitrophenylated at 40°C for two hours, the excess of DNFB 
was extracted with ether. The DNP-peptide in the aqueous phase was 
concentrated to dryness under reduced pressure and redissolved in 4 ml 
of constant boiling point HC1 and hydrolyzed in sealed tubes at 105°C 
for 24 hours. The N-terminal DNP-amino acid was extracted three 
times from the hydrolyzate with 10 ml of ether. This ether extract 
was transferred into a heart-shaped flask (MILLS' apparatus)10' in order 
to evaporate to dryness under reduced pressure. Then the flask was 
connected to the coldfinger, and the content was evacuated by a vacuum 
pump in order to remove as much dinitrophenol as possible. 
   Identification of the DNP-amino acids was carried out by ascending 
paper chromatography on Toyo filter paper No. 51 (40cm x4Ocm). For 
the first dimension, the developer was the upper phae of an n-butanol-
1 N NH4OH (1 : 1) mixture; the second dimension, 0.5 M phosphate 
buffer. Yellow spots on the paper were cut out and and eluted with 
5 ml of warm water. The quantitative determination was performed 
by measurement of the optical density at 360 mu of this eluate. 
   7) PTC Method for Amino Acid Sequence Analysis of the Peptides 
   EDMAN'S original method' '7' was modified for phenylisothiocyanation 
of the peptides. The ring-formation was performed with trifluoroacetic 
acid. 11) Analysis was carried out by the elimination methods' by 
comparing the amino acid compositions of the PTC-peptidos with the 
original peptides. 
   A sample of each peptide (0.5-2.0 umole) was dissolved in 2.5 ml 
of 66 % pyridine in a heart-shaped flask and to this was added 0.05 
ml of phenylisothiocyanate (PTC). The PTC reaction was performed at 
37°C for three hours after adjusting the reaction mixture ti pH 7.5. The 
reaction mixture was concentrated to dryness under reduced pressure. 
The excess PTC was removed by 30 minute aspiration with a vacuum 
pump by connecting the flask to the cold finger. To this was added 
1 ml of trifluoroacetic acid in order to occur the ring-formation. This 
was allowed to stand at room temperature for four hours. After the 
reaction, trifluoroacetic acid was removed under reduced pressure. 
The dry residue was dissolvod in 3 ml of deionized water and extracted 
with 3 ml of benzene three times. Consequently, the PTH-amino acids 
were extracted in the benzene phase. 
   The original peptide lost its N-terminal residue and remained in 
the aqueous phase. An aliquot of the aqueous phase was concentrated 
to dryness after HCl-hydrolysis and subjected to amino acid analysis. 
The remainder of the aqueous phase after the concentration to dryness 
was forr the following stage of the PTC method.
   8) Amino Acid Analysis of the Peptides 
   Each peptide was dissolved in 4 ml of constant boiling point HC1 
(twice distilled)and was hydrolyzed in sealed tubes at 105°C for 24 hours. 
The HCl was removed from the hydrolyzate by repeating dissolution in 
water and concentration to dryness. The amino acid analysis was 
carried out on Hitachi KLA-2 amino acid analyzer. The losses of the 
amino acids during the hydrolysis were not corrected and the composi-
tions were indicated by molecular ratios of the amino acids.
              RESULTS AND DISCUSSION 
   1) Preparation of the tryptic peptides 1T9, 8T13, 1T 14, and 1 T J5 
   Table I shows the amino acid compositions and. the yields of i T9, 
/9T 13, PST 14, and PPT 15 which were obtained by paper and column 
chromatographies from the tryptic hydrolyzate of 1 g of p-chain in 
macaca mulatta monkey hemoglobin.
Table I Amino acid compositions of the soluble tryptic 
        peptides, j9T 9, iT 13, iT 14, and RT 15 from 
          ,8-chain in macaca mulatta monkey hemoglobin
Peptide Lys His Arg Asp Thr Ser IGlu Pro Gly Ala Cys Val Met Leu Tyr Phe Try Yield* 
(3T 9 1.05 0.97 3.89 0.89 2.1311. 08 0.901 4.08 j 0.96 29 mmole 
PT 13 1.00 0.85' 3.94 1.14 1.98 0.961 I0.761 0.97 31 
i OT 14 1.02 0.98 1.04 0.86 3.76 2.541 1.13 38 
(3T 15 1.13 1 0.86 42
* This row shows the umole numbers of the peptides obtained from lg of /9-chain.
   These peptides seem to be nearly pure since the molecular ratios 
of their amino acids are near the integral values except valine in QT14. 
It is considered that three valine residues are in 9T14. The low value 
of valine may result from the strong resistance of Val-Val bond against 
HC1 hydrolysis. 
   2) Amino acid sequence of ,8T9 
   i9T9 consists of 16 amino acid residues. The composition is shown 
in Table I. As reported by TAKEI, 22' this peptide has aspartic acid one 
mole more and alanine one mole less than i9T 9 of human hemoglobin. 
By DNP method the N-terminal amino acid of this peptide turned out 
to be valine. The peptide was hydrolyzed with pepsin for 20 hours. 
The peptic peptides were first subjected to column chromatography and
                                  Fraction No. 
Fig. 1 Chromatography of peptic peptides of jT9 on Dowex 1 x 2 Column: 1.O X 
         60cm, Developer: Starting, 1 % Pyridine 1% collidine acetate buffer
         pH 8.5 Gradient 1, Mixing chamber 550 ml of starting buffer, upper 
         chamber 0.1N acetic acid, Gradient 2, upper chamber 1.0 N acetic acid
then to paper chromatography for the isolation and purification. The 
results are shown in Fig. 1 and Fig. 2. 
   Seven segmentary peptides were obtained as shown in Fig. 2. The 
analyses of the amino acid sequences of these peptides were carried out 
by the undermentioned procedure. Rf Leu in the explanation means 
the Rf value of each peptide against leucine. The value given in per 
cent (%) is the yield of the peptide through all the procedures. 
   a) / T9 P-I Rf Leu 0.43 23% 
   Lys : 1.04, His : 0.98, Asp : 1.96, Leu : 2.02 
The PTC method was carried out in two steps. 
   Step 1 : His : 0.02, Leu : 2.05, Asp : 1.95, Lys : 1.03 
   Step 2 : His : 0.00, Leu : 1.12, Asp : 2.00, Lys : 1.05 
From this result, the sequence of this peptide is considered to be His-
Leu-(Asp 2, Leu 1, Lys 1), that is, His-Leu-jT9PIIa. 
   b) 8T9 P-11a Rf Leu 0.38 29% 
   Lys : 1.00, Asp: 1.93, Leu : 1.07 
The PTC method was carried out in two steps.
                            Peak number in Fig.. 1 
Fig. 2 Paper chromatography of peptic peptides of (3T9 n-butanol: acetic 
        acid: water (4 : 1 : 5).
   Step 1 : Asp : 1.00, Leu 1.00, Lys, not determined 
   Step 2 : Asp : 0.26, Leu 1.00, Lys, not determined. 
This peptide had been known neutral by the paper electrophoresis. 
This suggests that one of the two residues which are present as aspartic 
acid is in fact asparagine. The peptide after the first step of the PTC 
method moved further to the cathode in the electrophoresis than the 
original peptide, suggesting that it was basic and that asparagine is not 
the N-terminal amino acid, but the second from the N-terminus of this 
peptide. As lysine is likely to be the C-terminal amino acid of 9T9, 
the sequence of (T9 PIIa was determined as follows; 
            Asp-Asp (NH,)-Leu-Lys 
This peptide appears to be located in the C-terminus of M. 
   c) 9T9 P-11b Rf Leu 1.10 80% 
   Gly : 1.00, Ala : 1.06, Val : 0.95, Leu : 0.99 
The PTC method was carried out in three steps. 
   Step 1 : Val: 0.00, Leu : 0.97, Gly : 1.01, Ala : 1.02
   Step 2 : Val : 0.00, Leu : 0.06, Gly : 1.00, Ala : 1.00 
   Step 3 : Val : 0.00, Leu : 0.00, Gly : 0.16, Ala : 1.00 
This appears to be the N-terminal peptide of jT9 since it has the only 
one valine that 19T9 has, and this valine has been already known to be 
the N-terminal. amino acid of QT 9. The amino acid sequence was 
determined as follows; 
             Val-Leu-Gly-Ala 
   d) QT9 P-III Rf Leu 0.52 16% 
   Lys : 1.04, His : 1.02, Asp : 3.92, Ser : 0.93, Gly : 0.98, Leu 
   3.12, Phe : 0.99 
By the DNP method, the N-terminal amino acid of this peptide was 
phenylalanine. Judging from its amino acid composition, this peptide is 
deduced to be a combination of QT9 P-IV and 9T°9 P-11a, and that of 
/9T9 P-Va and PT9 P-I. 
   e) QT9 P-IV Rf Leu 0.80 20% 
   His : 0.98, Asp : 1.98, Ser : 0.84, Gly : 1.01, Leu : 2.23, Phe 
   0.89 
   f) j3T9 P-Va Rf Leu 0.71 25% 
   Asp : 2.05, Ser : 0.96, Gly : 1.01, Leu : 1.04, Phe : 0.92 
The PTC method was carried out in five steps, and the peptide after 
every step was examined by electrophoresis. 
   Step 1 : Phe : 0.00, Ser : 0.90, Asp : 2.02, Gly : 1.02, Leu : 1.05 
   Step 2 : Phe : 0.00, Ser : 0.06 Asp : 1.91, Gly : 1.07, Leu : 1.02 
   Step 3 : Phe : 0.00, Ser : 0.00, Asp : 1.18, Gly : 0.98, Leu : 0.94 
   Step 4 : Phe : 0.00, Ser : 0.00, Asp : 0.99, Gly : 0.26, Leu : 1.01 
   Step 5 : Phe. 0.00, Ser : 0.00, Asp : 1.00, Gly : 0.08, Leu : 0.38 
This peptide wa originally acidic, but became neutral after the third 
step. In addition, by the C-terminal analysis wth carboxypeptidase A, 
asparagine was detected earliest. It was known that the peptide (9T9 
P-Vb, which had aspartic acid one mole less than this peptide, moved 
in the same manner as this peptide; in the electrophoresis. From the 
above-mentioned results, the amino acid sequence of this peptide was 
determined as follows; 
            Phe-Ser-Asp-Gly-Leu-Asp(NHZ) 
   g) jT9 P-Vb Rf Leu 0.92 5% 
   Asp : 1.03, Ser : 0.09, Gly : 0.08, Leu : 1.03, Phe : 1.06 
As mentioned above, this is a peptide which has aspartic acid one 
residue less than RT9 P-Va. 
   Putting all the above-mentioned results together, the amino acid 
sequence of /9T9 was determined as follows;
   This was compared with the sequence of the corresponding peptide 
of human hemoglobin. One difference was recognized at the tenth 
from the N-terminus, that is, it was alanine in case of human hemog-
lobin, but asparagine in case of macaca mulatta monkey hemoglobin. 
Except this difference, their amino acid sequences were quite similar 
to each other. 
   3) Amino acid sequence of 19T13 
   The amino acid composition of F?T13 is given in Table I. 
This peptide has glutamic acid one mole more and proline one mole less
        Fraction number 
Fig. 3 Chromatography of peptic peptides of f T13 on Dowex 1 x 2 
         Column : 1.0 x 60cm. Developer : Starting, 1 % pyridine 1% Picoline 
         acetate buffer pH 8.5; Gradient 1, Mixing chamber 750 nil of starting 
         buffer upper chamber 0.075N acetic acid: Gradient 2, upper chamber 
         1.0 N acetic acid.
Peak number in Fig. 3
Fig. 4 Paper chromatography of peptic peptides of OT13 
         n-butanol : acetic acid : water (4 : 1 : 5)
than ;JT13 of human hemoglobin. The N-terminal amino acid of this 
peptide was first determined to be glutamic acid by the DNP method. The 
fragmentary peptides were obtained by the hydrolysis of /=TB with 
pepsin for 16 hours. They were isolated by column chromatography. 
As shown in Fig. 3, three peaks were recognized. Each peak was 
subjected to paper chromatography. 
On the paper chromatogram, all the peaks presented only one spot, 
respectively. Therefore, the peptide contained in each peak had not 
to be purified further. The amino acid sequence of each peptide was 
determined. 
   a) QT13 P-I Rf Leu 0.20 82% 
   Lys : 0.96, Glu : 1.04, Tyr : 0.98 
The PTC method was carried out in one step. 
   Step I : Tyr : 0.07, Glu : 1.02, Lys : 0.98 
This peptide had been known to be basic by the electrophoresis. This 
suggests that the amino acid detected as glutamic acid residue in the 
amino acid analysis is in fact a glutamine residue. Lysine was the 
C-terminal amino acid of 9T13. Therefore, this peptide is located in 
the C-terminus of ,8T13. The sequence was determined as follows;
            Tyr-Glu(NHZ)-Lys 
   b) RT13 P-II Rf Leu 0.68 80% 
   In the analysis of this peptide after HC1 hydrolysis, alanine was 
only detected. The Rf value of this peptide on the paper chromatogram 
was, however, higher than that of alanine. PT13 had presumably two 
residues of alanine. Therefore, this peptide may consist of Ala-Ala. 
    In order to confirm this presumption, the following analysis was 
carried out by the DNP method. The peptide (0.2 umole) was dinitro-
phenylated in 1 % NaHCO, and the excess DNFB was removed by the 
ether extraction. The aqueous phase was acidified by the addition of 
HC1 and was again extracted with ether. Consequently, DNP-Ala-Ala 
was extracted in the ether phase. If irresponsive Ala-Ala or Ala 
existed, it must have been left in the aqueous phase by this operation. 
The ether phase containing DNP-AIa-Ala was dried and then hydrolyzed 
with constant boiling point HC1 at 105°C for 20 hours. From this 
hydrolyzate, the DNP-Ala which was due to the N-terminus was 
extracted in the ether phase, and other residue of alanine, in the 
aqueous phase. The DNP-Ala in the ether phase was isolated, purified, 
and determined quantitatively by the two-dimensional paper chromato-
graphy. On the other hand, the isolated alanine in the aqueous phase 
was dinitrophenylated in the same way as mentioned above. It was 
subjected to the paper chromatography for the isolation and the quan-
titative determination. As the results, 0.136 umole of the DNP-Ala due 
to the N-terminus and 0.126 umole of the DNP-Ala which was not due to 
the N-terminus were obtained. This fact proves that 9T13 P-11 is a 
dipeptide Ala-Ala. 
   c) 9T13 P-111 Rf Leu 0.47 75% 
   Thr : 0.90, Glu : 3.01, Pro : 1.07, Val : 0.97, Phe : 1.05 
The PTC method was carried out in six steps, and the peptide after 
every step was examined by electrophoresis in order to know its 
approximate electric charge. 
   Step 1 : Glu : 2.16, Phe : 0.97, Thr : 0.95, Pro : 1.10, Val : 0.99 
   Step 2 : Glu : 2.04, Phe : 0.06, Thr 0.94, Pro : 1.08, Val : 0.98 
   Step 3 : Glu 1.98, Phe : 0.00, Thr : 0.05, Pro : 1.02, Val : 0.97 
   Step 4 Glu : 2.04, Phe : 0.00, Thr : 0.05, Pro : 0.08, Val : 0.96 
   Step 5 : Glu : 1.32, Phe : 0.00, Thr : 0.00, Pro : 0.00, Val : 1.00 
   Step 6 : Glu : 1.00, Phe : 0.00, Thr : 0.00, Pro : 0.00, Val: 0.20 
This peptide was originally acidic, but changed into neutral after the 
first step. Even after the fifth step, it remained neutral. This 
indicates that except the N-terminal glutamic acid, the residues detected 
as glutamic acids in the analysis are all glutamine. Accordingly, the 
amino acid sequence of this peptide was determined as follows; 
            Glu-Phe-Thr-Pro-Glu (NHZ)-V al-Glu (NHZ)
Moreover, this peptide is considered to be located in the N-terminus of 
,8T13, since glutamic acid is the N-terminal amino acid. 
   Putting the results of the analyses of the three fragmentary peptides 
together, the amino acid sequence of 9T13 was determined as follows;
   This sequence was compared with that of i9T13 of human hemoglo-
bin. The fifth amino acid from the N-terminus was different from 
each other. Namely, it is proline in human hemoglobin, but glutamine 
in macaca mulatta monkey hemoglobin. 
   4) Amino acid sequence of gT14 
   The amino acid composition of this peptide is shown in Table I. 
It is quite similar to that of human hemoglobin. 
   By the DNP method, the N-terminal amino acid of this peptide was
Fig . 5 Chromatography of peptic peptides of jlT14 on Dowex 1 x 2 
         column : 1.0 x 60cm, Developer : starting, 1 °o pyridine 1% picoline 
         acetate buffer pH 8. 5 ; gradient, mixing chamber, 600 ml of starting 
         buffer, upper chamber 0.1 N acetic acid
Peak number in Fig. 5
Fig. 6 Paper chromatography of peptic peptides of (3T]4 
         n-butanol : acetic acid: water (4 : 1 : 5)
known to be valine. The peptide was first hydrolyzed with pepsin 
for 20 hours. The peptic peptides were isolated by column and paper 
chromatographies. The results are shown in Fig. 5 and Fig. 6. 
   a) iT14 P-I Rf Leu 0.17 70% 
   Lys : 0.96, His : 1.04, Ala : 1.01, Leu, : 0.99 
The PTC method was carried out in two steps. 
   Step 1 : Leu : 0.06, Ala : 0.98, His : 1.02, Lys : 1.00 
   Step 2 : Leu : 0.06, Ala 0.08, His : 0.96, Lys 1.04 
Since lysine appeares to be the C-terminal amino acid of RT14, this 
peptide is located at the C-terminus of 9T14. The sequence was deter-
mined as follows; 
             Leu-Ala-His-Lys 
   b) iT14 P-II Rf Leu 0.78 27% 
   Asp : 0.99, Gly : 1.08, Ala : 3.01, Val : 2.44 
The combination of this peptide and 9T14 P-I is identical to 9T14 in 
the amino acid composition. Therefore, it is considered that this 
peptide is located at the N-terminus of ,9T 14 and that this peptide is 
the combination of 8T14 P-111a and 8T14 P-IIIb. The PTC method
was carried out in two steps. 
    Step 1 : Val : 2.01, Ala : 3.00, Gly : 0.96, Asp : 1.04 
    Step 2 : Val : 0.98: Ala : 2.92, Gly : 1.08, Asp : 1.00 
From this result, it is known that the N-terminus of QT 14 consists of 
Val-Val bond. 
   c) 8T14 P-111a Rf Leu 0.60 29% 
    Asp : 1.00, Ala : 2.01, Val : 0.99 
The PTC method was carried out in three steps. 
    Step 1 : Val : 0.00, Ala : 2.04, Asp : 0.96 
    Step 2 : Val : 0.00, Ala : 0.99, Asp : 1.01 
   Step 3 : Val : 0.00, Ala : 1.00 Asp : 0.06 
By electrophoresis, this peptide turned out to be neutral. This suggests 
that the residue detected as aspartic acid in the analysis is asparagine. 
The sequence was determined as follows; 
           Val-Ala-Asp (NH2)-Ala
   d) ST14 P-111b Rf Leu 0.95 31% 
   Gly : 0.98, Ala : 1.02, Val : 1.44
The PTC method was carried out in three steps. 
   Step 1 : Val : 0.96, Ala : 1.04, Gly : 1.00 
   Step 2 : Val : 0.08, Ala : 1.02, Gly : 0.98 
   Step 3 : Val : 0.08, Ala : 0.13, Gly : 1.00 
Accordingly, the amino acid sequence of this peptide was determined 
as follows; 
            Val-Val-Ala-Gly 
It is considered that this is the N-terminal peptide of aT 14 because 
Val-Val bond exists at the N-terminus of this peptide. 
   From the above-mentioned results, the amino acid sequence of 
RT14 was determined as follows;
This is quite the same as the sequence of RT14 in human hemoglobin. 
   5) Amino acid sequence of,8T1.5 
   QT15 is a dipeptide which consists of histidine and tyrosine. By 
the DNP method di-DNP-tyrosine was detected, and in the amino acid 
analysis after the first step of the PTC method only histidine was 
recognized. Therefore the amino acid sequence of this peptide was 
Tyr-His. This is quite the same as 9T15, the C-terminal peptide of
j9-chain in human hemoglobin.
CONCLUSION
   The present author chose four, i. e. QT9, 8T13, 9T14, and 8T15 ., 
among the peptides obtained by the tryptic hydrolysis of Q-polypeptide 
chain of macaca mulatta monkey hemoglobin, and determined the amino 
acid sequences of these four peptides which contain 42 amino acid 
residues. Moreover, he compared the results with the amino acid 
sequences of the corresponding peptides of human hemoglobin. Two 
differences were recognized between the two hemoglobins. Namely, 
the tenth amino acid from the N-terminus of QT9 was alanine in case 
of human hemoglobin, but asparagine in case of macaca mulatta monkey 
hemoglobin. The fifth from the N-terminus of jT13 was proline in 
case of the former, but glutamine in cass of the latter.
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